Found: 16
Select item for more details and to access through your institution.
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.029
- By:
- Publication type:
- Article
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3399, doi. 10.3390/ijms21093399
- By:
- Publication type:
- Article
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
The diagnostic role of Next Generation Sequencing in uncovering isolated splenomegaly: A case report.
- Published in:
- Hematology Reports, 2021, v. 13, n. 2, p. 1, doi. 10.4081/hr.2021.8814
- By:
- Publication type:
- Article
RESTORATION OF THE FRIEZE BY ARISTIDE SARTORIO IN THE CHAMBER OF DEPUTIES OF THE ITALIAN PARLIAMENT.
- Published in:
- Conservation Science in Cultural Heritage / Quaderni di Scienza della Conservazione, 2019, v. 19, p. 99
- By:
- Publication type:
- Article
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2449, doi. 10.1002/cncr.34216
- By:
- Publication type:
- Article
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2657, doi. 10.1002/cncr.33541
- By:
- Publication type:
- Article
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 190, doi. 10.1111/bjh.18057
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients' satisfaction.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. e48, doi. 10.1111/bjh.17208
- By:
- Publication type:
- Article
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 987, doi. 10.1111/bjh.15682
- By:
- Publication type:
- Article
Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 424, doi. 10.1111/bjh.15668
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 409, doi. 10.1002/hon.2843
- By:
- Publication type:
- Article
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 5, p. 963, doi. 10.1007/s00277-022-04786-y
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article